Sma News & Perspectives

Muscle and Combo Therapies Likely Next Focus for SMA & DeAnn Runge's 3 Year Journey With Spinraza

Informações:

Sinopsis

SMA News Today’s multimedia associate, Price Wooldridge, discusses the likely next focus of muscle and combo therapies for Spinal Muscular Atrophy (SMA). DeAnn Runge shares her thoughts on her 3 year journey with Spinraza. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/